company

STIFTELSEN TIL FREMME AV FORSKNING PÅ HJERTE-, KAR- OG LUNGESYKDOMMER, INKLUSIVE KREFTSYKDOMMER

Return on Equity
−14,38 %
Current Ratio
N/A
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue−2 251 000
Net Income−2 485 000
Total Assets17 281 000
Total Equity17 281 000
Income (NOK)2022
Revenue−2 251 000
Expenditure61 000
Operating Profit−2 312 000
Financial Income0
Financial Costs173 000
Financial Balance−173 000
Earnings Before Tax−2 485 000
Tax0
Net Income−2 485 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets17 281 000
Total Assets17 281 000
Total Retained Equity11 476 000
Total Equity17 281 000
Total Long-Term Debt0
Total Current Debt0
Total Equity and Debt17 281 000
Cash flow (NOK)2022
Sales Income0
Other Income−2 251 000
Revenue−2 251 000
Cost of Goods Sold0
Salary Costs54 000
Depreciation0
Impairment0
Expenditure61 000
Operating Profit−2 312 000
Financial Income0
Financial Costs173 000
Financial Balance−173 000
Dividends0
Net Income−2 485 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments16 854 000
Cash, Bank426 000
Total Current Assets17 281 000
Total Assets17 281 000
Total Equity17 281 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt0
Total Equity and Debt17 281 000
Financial indicators2022
Return on Equity−14,38 %
Debt-to-Equity Ratio0
Operating Profit Margin102,71 %
Current Ratio-
Quick Ratio-
Equity Ratio1
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English